enVVeno Medical Corp
NVNO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001661053
In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $123.31 in total
- 1
- 13F holdersQ2 2026, 0 vs. previous quarter
- 17
- 13F valueReported value at the end of Q2 2026
- $953.6K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding NVNO, Q2 2026
No superinvestor reported holding NVNO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by enVVeno Medical Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 (view filing)6:56 PM ET | Sep 11 | 3 days | Duhay FrancisDirector | SSale | −11 | $11.21 | −$123.31 | −0.5%2.35K after | 10b5-1 |
| Jun 12, 2026 (view filing) | Jun 11 | 1 day | Duhay FrancisDirector | SSale | −140 | $10.31 | −$1.44K | −5.6%2.36K after | 10b5-1 |
| Mar 13, 2026 (view filing) | Mar 12 | 1 day | Duhay FrancisDirector | SSale | −140 | $11.52 | −$1.61K | −5.3%2.50K after | 10b5-1 |
| Dec 12, 2025 (view filing)4:40 PM ET | Dec 11 | 1 day | Duhay FrancisDirector | SSale | −4.90K | $0.3556 | −$1.74K | −5.0%92.5K after | 10b5-1 |
| Sep 17, 2025 (view filing) | Sep 15 | 2 days | Duhay FrancisDirector | SSale | −4.90K | $0.83 | −$4.07K | −4.8%97.4K after | 10b5-1 |
| Jan 3, 2025 (view filing) | Dec 31, 2024 | 3 days | Duhay FrancisDirector | PPurchase | +81.4K | $3.07 | +$250.0K | +389.4%102.3K after | |
| Jan 2, 2025 (view filing) | Dec 31, 2024 | 2 days | Gray RobertDirector | PPurchase | +3.50K | $2.94 | +$10.3K | +45.7%11.2K after | |
| Dec 26, 2024 (view filing) | Dec 24 | 2 days | Shrivastava SanjayDirector | PPurchase | +5.40K | $2.90 | +$15.7K | +138.9%9.29K after | |
| Dec 23, 2024 (view filing) | Dec 19 | 4 days | Jenusaitis MatthewDirector | PPurchase | +9.62K | $2.53 | +$24.3K | +138.9%16.5K after | |
| Dec 19, 2024 (view filing) | Dec 19 | Same day | Berman Robert AndrewChief Executive Officer | PPurchase | +12.0K | $2.55 | +$30.6K | +5.7%222.2K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in enVVeno Medical Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kingdon Capital Management, L.L.C. | 36,166 | $387.3K | 0.05% | 00.0% | Unchanged |
| CM Management, LLC | 35,714 | $382.5K | 0.24% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 6,287 | $67.4K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 5,208 | $59.1K | 0.00% | −10.0% | Reduced |
| Vanguard Fiduciary Trust Co | 2,184 | $23.4K | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 1,525 | $16.3K | 0.00% | −64−4.0% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 539 | $5.77K | 0.00% | +539 | New |
| BlackRock, Inc. | 414 | $4.43K | 0.00% | −1,426−77.5% | Reduced |
| Tower Research Capital LLC (TRC) | 331 | $3.54K | 0.00% | −211−38.9% | Reduced |
| Wells Fargo & Company | 114 | $1.22K | 0.00% | 00.0% | Unchanged |